Rx only · Solution · Ophthalmic

Bepotastine Besilate

1 ACTIVE SUPPLIER — US

openFDA · updated weekly

US2 NDCs
1 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATC—

RxCUI (US)863035

US makers1 labelers

Packages2

DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$9.856

Latest avg · Jul 22, 2026

-32%

Since Dec 17, 2025

Active US suppliers

100%

Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

360

Rx · 2026 Q1

2.0K

Units dispensed

Quarters · since 2025 Q2

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
Somerset Therapeutics, LLC	unknown	2	SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.